Tevis Investment Management Acquires Shares of 6,701 Doximity, Inc. $DOCS

Tevis Investment Management acquired a new stake in Doximity, Inc. (NASDAQ:DOCS) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 6,701 shares of the company’s stock, valued at approximately $411,000.

Several other institutional investors also recently bought and sold shares of DOCS. GAMMA Investing LLC grew its holdings in Doximity by 62.3% in the first quarter. GAMMA Investing LLC now owns 2,816 shares of the company’s stock valued at $163,000 after purchasing an additional 1,081 shares during the period. Wealth Enhancement Advisory Services LLC grew its holdings in Doximity by 196.6% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 13,570 shares of the company’s stock valued at $787,000 after purchasing an additional 8,995 shares during the period. Spire Wealth Management boosted its stake in shares of Doximity by 73.2% in the first quarter. Spire Wealth Management now owns 615 shares of the company’s stock worth $36,000 after acquiring an additional 260 shares during the last quarter. Bessemer Group Inc. boosted its stake in shares of Doximity by 214.2% in the first quarter. Bessemer Group Inc. now owns 1,398 shares of the company’s stock worth $81,000 after acquiring an additional 953 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. acquired a new stake in shares of Doximity in the first quarter worth approximately $6,019,000. 87.19% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction that occurred on Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total transaction of $1,500,000.00. Following the transaction, the director owned 3,221 shares in the company, valued at approximately $241,575. This trade represents a 86.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Regina M. Benjamin sold 5,000 shares of Doximity stock in a transaction on Friday, October 10th. The shares were sold at an average price of $70.84, for a total value of $354,200.00. Following the completion of the sale, the director owned 19,839 shares in the company, valued at $1,405,394.76. This represents a 20.13% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 37,000 shares of company stock worth $2,635,880. 31.30% of the stock is owned by corporate insiders.

Doximity Stock Performance

Shares of Doximity stock opened at $68.47 on Tuesday. Doximity, Inc. has a one year low of $41.03 and a one year high of $85.21. The company has a market cap of $12.82 billion, a price-to-earnings ratio of 68.47, a PEG ratio of 4.10 and a beta of 1.38. The business’s 50 day moving average price is $69.65 and its 200 day moving average price is $61.94.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter in the prior year, the business earned $0.28 EPS. The business’s revenue for the quarter was up 15.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, analysts predict that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Raymond James Financial set a $75.00 price target on Doximity in a research note on Wednesday, September 10th. KeyCorp lifted their price target on Doximity from $75.00 to $80.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Bank of America raised Doximity from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $75.00 to $82.00 in a research note on Monday. JPMorgan Chase & Co. reaffirmed an “underweight” rating and issued a $62.00 price target on shares of Doximity in a research note on Friday, October 10th. Finally, Wells Fargo & Company lifted their price target on Doximity from $55.00 to $62.00 and gave the stock an “equal weight” rating in a research note on Monday, August 4th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $70.42.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.